生发中心反应产生N-甲基-D-天冬氨酸受体抗体:治疗意义
研究纳入10例NMDAR抗体脑炎患者,检测血清NR1-IgM/IgG,并体外刺激外周血单个核细胞及2例卵巢畸胎瘤组织。6/10例血清NR1-IgM阳性;90%患者B细胞可分化为分泌NR1-IgM和NR1-IgG的抗体分泌细胞,分泌NR1-IgG与血清NR1-IgG相关(p<0.0001);畸胎瘤浸润淋巴细胞可产生NR1-IgG,提示持续生发中心反应可能为治疗靶点。
要点
- 6/10例NMDAR抗体脑炎患者血清检出NR1-IgM,常于起病前后最高并持续数月。
- 90%患者外周血B细胞体外可分化为分泌NR1-IgM和NR1-IgG的抗体分泌细胞。
- 卵巢畸胎瘤浸润淋巴细胞可在培养中产生NR1-IgG,提示生发中心反应参与抗体产生。
核心结论
- 血清NR1-IgM和NR1-IgG以及循环B细胞和卵巢畸胎瘤持续产生NR1-IgG,提示持续生发中心反应可能解释分泌NR1-IgG的外周细胞群体,参与生发中心反应的细胞可能是NMDAR抗体脑炎的治疗靶点。
研究设计与样本
- 研究检测10例NMDAR抗体脑炎患者的临床数据和纵向配对血清NR1反应性IgM和IgG水平。
- 体外用免疫因子组合刺激这10例患者的外周血单个核细胞和2例可获得的卵巢畸胎瘤,检测总IgG和NR1特异性抗体分泌。
主要发现
- 除疾病定义性NR1-IgG外,10例患者中6例血清NR1-IgM阳性。
- NR1-IgM水平通常在疾病起病前后最高,并可在病程中检测到数月。
- 患者循环B细胞在体外分化为CD19+ CD27++ CD38++抗体分泌细胞,且90%患者分泌NR1-IgM和NR1-IgG。
- 分泌的NR1-IgG水平与血清NR1-IgG相关(p < 0.0001),且在不同疾病持续时间中均观察到,提示为持续过程。
- 卵巢畸胎瘤组织含有浸润淋巴细胞,在培养中产生NR1-IgG。
临床怎么用
- 作者认为,参与生发中心反应的细胞可能是治疗NMDAR抗体脑炎的靶点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: N-methyl-D-aspartate receptor (NMDAR) antibody encephalitis is mediated by immunoglobulin G (IgG) autoantibodies directed against the NR1 subunit of the NMDAR. Around 20% of patients have an underlying ovarian teratoma, and the condition responds to early immunotherapies and ovarian teratoma removal. However, despite clear therapeutic relevance, mechanisms of NR1-IgG production and the contribution of germinal center B cells to NR1-IgG levels are unknown. METHODS: Clinical data and longitudinal paired serum NR1-reactive IgM and IgG levels from 10 patients with NMDAR-antibody encephalitis were determined. Peripheral blood mononuclear cells from these 10 patients, and two available ovarian teratomas, were stimulated with combinations of immune factors and tested for secretion of total IgG and NR1-specific antibodies. RESULTS: In addition to disease-defining NR1-IgG, serum NR1-IgM was found in 6 of 10 patients. NR1-IgM levels were typically highest around disease onset and detected for several months into the disease course. Moreover, circulating patient B cells were differentiated into CD19+ CD27++ CD38++ antibody-secreting cells in vitro and, from 90% of patients, secreted NR1-IgM and NR1-IgG. Secreted levels of NR1-IgG correlated with serum NR1-IgG (p < 0.0001), and this was observed across the varying disease durations, suggestive of an ongoing process. Furthermore, ovarian teratoma tissue contained infiltrating lymphocytes which produced NR1-IgG in culture. INTERPRETATION: Serum NR1-IgM and NR1-IgG, alongside the consistent production of NR1-IgG from circulating B cells and from ovarian teratomas suggest that ongoing germinal center reactions may account for the peripheral cell populations which secrete NR1-IgG. Cells participating in germinal center reactions might be a therapeutic target for the treatment of NMDAR-antibody encephalitis. Ann Neurol 2018;83:553-561.
引用
- Makuch M, Wilson R, Al-Diwani A, et al. N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications. Ann Neurol. 2018. PMID: 29406578. doi:10.1002/ana.25173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。